20 February 20, 2024Announcement no. 02 Roche Diagnostics and BioPorto expand collaboration COPENHAGEN, DENMARK and BOSTON, MA, 20 February, 2024, (GLOBE NEWSWIRE) BioPorto A/S (BioPorto or the...
Health Canada Issues Recall of Roche Diagnostics` Elecsys® Troponin T Hs
MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the second quarter and first half year of 2022.
Nordic Bioscience, a growing biomarker company, today announced the strengthening of its ongoing collaboration with Roche Diagnostics for the...
A federal appeals court overturned a $137 million verdict against Roche Diagnostics on Friday in a Delaware patent infringement case — but the pharma giant isn’t completely out of the woods.
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and DeltaThe World...
WARRINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute...
TORONTO, March 07, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced the closing of its previously-announced acquisition...
Evrysdi® (risdiplam) data further confirm long-term efficacy and safety data in a broad range of people with spinal muscular atrophy (SMA)Latest interim results from the RAINBOWFISH study demonstrate...
WALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a strategic partnership with Roche Diagnostics USA, a division of the world’s largest biotech company and a global pioneer in pharmaceuticals and diagnostics.